Tobacco smokers titrate their
nicotine intake to avoid its noxious effects, sensitivity to which may influence vulnerability to
tobacco dependence, yet mechanisms of
nicotine avoidance are poorly understood. Here we show that
nicotine activates
glucagon-like peptide-1 (GLP-1) neurons in the nucleus tractus solitarius (NTS). The
antidiabetic drugs sitagliptin and
exenatide, which inhibit
GLP-1 breakdown and stimulate
GLP-1 receptors, respectively, decreased
nicotine intake in mice. Chemogenetic activation of
GLP-1 neurons in NTS similarly decreased
nicotine intake. Conversely, Glp1r knockout mice consumed greater quantities of
nicotine than wild-type mice. Using optogenetic stimulation, we show that
GLP-1 excites medial habenular (MHb) projections to the interpeduncular nucleus (IPN). Activation of
GLP-1 receptors in the MHb-IPN circuit abolished
nicotine reward and decreased
nicotine intake, whereas their knockdown or pharmacological blockade increased intake.
GLP-1 neurons may therefore serve as 'satiety sensors' for
nicotine that stimulate habenular systems to promote
nicotine avoidance before its aversive effects are encountered.